YSI launches FDA registered YSI 2900C 

YSI, a global leader in biochemical analysis solutions, proudly announces the launch of the YSI 2900C Biochemistry Analyzer, the latest advancement in blood glucose measurement and glucometer validation. The 2900C is Class II FDA registered, and designed for use in research, clinical validation, and manufacturing environments where accuracy, speed, and reliability are paramount.

Since introducing the first FDA-registered blood glucose analyser in 1989, the iconic YSI 2300 STAT set the benchmark for glucose measurement. For decades, the 2300 STAT has been considered the gold standard by glucometer manufacturers worldwide. The new YSI 2900C Biochemistry Analyzer builds on this legacy, delivering enhanced performance while maintaining the precision and reliability expected from YSI instruments.

Powered by Immobilised Enzyme Technology (IET), the YSI 2900C Biochemistry Analyzer enables rapid glucose analysis with minimal sample preparation. Users can simply load a sample and receive highly accurate results in approximately 60 seconds.

The YSI 2900C Biochemistry Analyzer features a large intuitive touchscreen for simplified operation, integrated autosampler for increased throughput, unique anti-clogging fluidics design for reduced maintenance, flexible sampling options (including 96-well plate compatibility, test tube, and syringe sampling), and robust connectivity for easy data integration.

Much like the proven YSI 2900 Series, the YSI 2900C Biochemistry Analyzer is trusted across clinical, food and beverage, and research laboratories. With its advanced features and regulatory approval, it is poised to become the instrument of choice for organisations validating commercial glucometers or conducting glucose research.

More information online